분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2013-02-22 08:32:31 , Hit : 3204
 Electronics Giant Samsung Makes First Big Biotech Play



GENNewsHighlights
More »  
Feb 20, 2013


Merck entered into an agreement with Samsung Bioepis to develop and commercialize multiple prespecified and undisclosed biosimilar candidates. Samsung Bioepis, which is a joint venture formed last year by Samsung Biologics and Biogen Idec to focus on biosimilars, has a R&D center based in Song-do Incheon, Korea.

Under the agreement, Samsung Bioepis will be responsible for preclinical and clinical development, process development and manufacturing, clinical trials, and registration. Merck will be responsible for commercialization. Samsung Bioepis will receive an up-front payment from Merck, product supply income, and will be eligible for additional payments associated with prespecified clinical and regulatory milestones.

“The combination of Merck’s global commercial presence with Samsung Bioepis’ biologic development and manufacturing capabilities positions the two companies well to increase access to biosimilars to improve human health,” said Rich Murray, Ph.D., senior vp, biologics and vaccines research, Merck Research Laboratories.

“Samsung Bioepis has been building the capabilities needed to develop high-quality biosimilars,” added Christopher Hansung Ko, Ph.D., CEO of Samsung Bioepis. “With this development and commercialization agreement, Samsung takes a significant step toward becoming a major player in the biopharmaceutical industry.”







1107   Dynamic view of the MS genome  이성욱 2010/05/01 2757
1106   Early-Earth cells modeled to show how first life forms might have packaged RNA  이성욱 2012/10/16 2586
1105   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 945
1104   Efficient Process Using microRNA Converts Human Skin Cells Into Neurons  이성욱 2011/07/19 2288
  Electronics Giant Samsung Makes First Big Biotech Play  이성욱 2013/02/22 3204
1102   EMA panel recommends approval of DAA regimen for patients with HCV  이성욱 2014/11/26 1341
1101   Embryonic stem cells improve vision for two women  이성욱 2012/01/25 2377
1100   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 936
1099   Engineered Viruses Selectively Kill Cancer Cells  이성욱 2011/09/02 2493
1098   Engineering Better Immune Cells  이성욱 2010/05/06 2737
1097   EU, 2번째 유전자치료제 ‘스트림벨리스’ 승인  이성욱 2016/09/05 1273
1096   European regulators back first gene therapy drug  이성욱 2012/07/24 2724
1095   Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice  이성욱 2019/01/15 1806
1094   Expanding the reach of gene editing with a new CRISPR enzyme  이성욱 2018/10/26 828
1093   Experimental Hepatitis C Drug Shows Promise for Preventing Recurrence in Liver Transplant Patients  이성욱 2013/11/06 2185
1092   Experts find rogue stem cells in liver cancer  이성욱 2011/07/09 2615
1091   Fathers Can Pass Mitochondrial DNA to Children  이성욱 2018/12/26 1808
1090   FDA approves 9-valent HPV vaccine for certain cancers  이성욱 2014/12/12 1223
1089   FDA Approves First Gene Therapy for Inherited Disease  이성욱 2017/12/22 674
1088   FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'  이성욱 2017/10/20 747

[1][2][3][4][5][6][7][8] 9 [10]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN